4.48
-0.12 (-2.51%)
| 前收盘价格 | 4.59 |
| 收盘价格 | 4.64 |
| 成交量 | 804,612 |
| 平均成交量 (3个月) | 1,325,130 |
| 市值 | 1,705,610,496 |
| 预期市盈率 (P/E Forward) | 13.40 |
| 价格/销量 (P/S) | 2.42 |
| 股市价格/股市净资产 (P/B) | 2.66 |
| 52周波幅 | |
| 利润日期 | 26 Feb 2025 - 3 Mar 2025 |
| 营业毛利率 | -2.05% |
| 营业利益率 (TTM) | 10.48% |
| 稀释每股收益 (EPS TTM) | -0.040 |
| 季度收入增长率 (YOY) | 8.50% |
| 季度盈利增长率 (YOY) | -88.60% |
| 总债务/股东权益 (D/E MRQ) | 78.19% |
| 流动比率 (MRQ) | 5.48 |
| 营业现金流 (OCF TTM) | 155.02 M |
| 杠杆自由现金流 (LFCF TTM) | 88.56 M |
| 资产报酬率 (ROA TTM) | 4.21% |
| 股东权益报酬率 (ROE TTM) | -2.06% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Health Information Services (US) | 混合的 | 看跌 |
| Health Information Services (全球的) | 混合的 | 看跌 | |
| 股票 | GoodRx Holdings, Inc. | 看跌 | 看涨 |
AIStockmoo 评分
| 分析师共识 | 1.0 |
| 内部交易活动 | NA |
| 价格波动 | 3.0 |
| 技术平均移动指标 | 3.5 |
| 技术振荡指标 | -0.5 |
| 平均 | 1.75 |
|
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services. |
|
| 部门 | Healthcare |
| 行业 | Health Information Services |
| 投资方式 | Small Core |
| 内部持股比例 | 11.90% |
| 机构持股比例 | 70.75% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Francisco Partners Management, Lp | 30 Sep 2024 | 70,078,184 |
| Petrus Trust Company, Lta | 30 Sep 2024 | 2,519,726 |
| Rip Road Capital Partners Lp | 30 Sep 2024 | 2,408,577 |
| Technology Crossover Management X, Ltd. | 30 Sep 2024 | 1,653,566 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 7.00 (Citigroup, 56.43%) | 购买 |
| 中 | 6.00 (34.08%) | |
| 低 | 6.00 (Morgan Stanley, 34.08%) | 保留 |
| 6.00 (Barclays, 34.08%) | 购买 | |
| 平均值 | 6.33 (41.45%) | |
| 总计 | 2 购买, 1 保留 | |
| 平均价格@调整类型 | 4.67 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Morgan Stanley | 17 Dec 2024 | 6.00 (34.08%) | 保留 | 4.46 |
| Citigroup | 13 Nov 2024 | 7.00 (56.42%) | 购买 | 4.66 |
| Barclays | 11 Nov 2024 | 6.00 (34.08%) | 购买 | 4.89 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合